To scroll text in this page

Global Navigation
Global Navigation end

About Astellas

Start of the main text

2012 News Releases

About RSS

AVEO and Astellas Announce Tivozanib Successfully Demonstrated Progression-FreeSurvival Superiority over Sorafenib in Patients with Advanced Renal Cell Cancer in Phase 3 TIVO-1 Trial (pdf 66KB)

January 4, 2012

Printer-friendly version

Main Text end
Local Navigation
Local Navigation end
Related Links